A Tiny Upstart Takes Aim at Robotic Surgery
Intuitive Surgical's (NASDAQ: ISRG) robots enjoy a near monopoly in hospitals, but that could change following last week's FDA approval of TransEnterix's (NYSEMKT: TRX) Senhance. Senhance is a robotic system that assists surgeons performing laparoscopic surgeries. It offers advantages, including haptic feedback, that could differentiate it from Intuitive Surgical's da Vinci system. Will TransEnterix carve out a meaningful slice of this fast-growing market?
Intuitive Surgical's ground-breaking da Vinci systems are reshaping laparoscopic surgery.
IMAGE SOURCE: TRANSENTERIX.
Source: Fool.com
Intuitive Surgical Inc Stock
With 72 Buy predictions and 2 Sell predictions Intuitive Surgical Inc is one of the favorites of our community.
With a target price of 512 € there is a hugely positive potential of 56.31% for Intuitive Surgical Inc compared to the current price of 327.55 €.


